Cargando…

Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation

Chronic Kidney Disease (CKD) is a debilitating disease associated with several secondary complications that increase comorbidity and mortality. In patients with CKD, there is a significant qualitative and quantitative alteration in the gut microbiota, which, consequently, also leads to reduced produ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magliocca, Giorgia, Mone, Pasquale, Di Iorio, Biagio Raffaele, Heidland, August, Marzocco, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140893/ https://www.ncbi.nlm.nih.gov/pubmed/35628164 http://dx.doi.org/10.3390/ijms23105354

Ejemplares similares

Inflammation and Oxidative Stress in Chronic Kidney Disease—Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites
por: Rapa, Shara Francesca, et al.
Publicado: (2019)

Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study)
por: Marzocco, Stefania, et al.
Publicado: (2018)

Protective Effect of Pomegranate on Oxidative Stress and Inflammatory Response Induced by 5-Fluorouracil in Human Keratinocytes
por: Rapa, Shara Francesca, et al.
Publicado: (2021)

DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers
por: Schupp, Nicole, et al.
Publicado: (2016)

Regulation of Inflammation by Short Chain Fatty Acids
por: Vinolo, Marco A.R., et al.
Publicado: (2011)

Correction of metabolic acidosis improves insulin resistance in chronic kidney disease
por: Bellasi, Antonio, et al.
Publicado: (2016)

Bioassay-Guided Isolation of Anti-Inflammatory Constituents of the Subaerial Parts of Cyperus articulatus (Cyperaceae)
por: Mittas, Domenic, et al.
Publicado: (2022)

Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The “Nutritional Light Signal” of the Renal Acid Load
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2017)

Roles of short-chain fatty acids in kidney diseases
por: Li, Ling-Zhi, et al.
Publicado: (2019)

Gut-brain axis: Focus on gut metabolites short-chain fatty acids
por: Guo, Cen, et al.
Publicado: (2022)

Microbiota metabolites in the female reproductive system: Focused on the short-chain fatty acids
por: Mirzaei, Rasoul, et al.
Publicado: (2023)

Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation
por: Kim, Chang H., et al.
Publicado: (2014)

Ketoanalogs’ Effects on Intestinal Microbiota Modulation and Uremic Toxins Serum Levels in Chronic Kidney Disease (Medika2 Study)
por: Rocchetti, Maria Teresa, et al.
Publicado: (2021)

Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer
por: Zeng, Huawei, et al.
Publicado: (2019)

Gut microbiota–derived short-chain fatty acids and kidney diseases
por: Li, Lingzhi, et al.
Publicado: (2017)

Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins
por: Schupp, Nicole, et al.
Publicado: (2010)

Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?
por: Ohira, Hideo, et al.
Publicado: (2017)

Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer
por: Carretta, María Daniella, et al.
Publicado: (2021)

Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)
por: Di Iorio, Biagio Raffaele, et al.
Publicado: (2019)

Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism
por: He, Jin, et al.
Publicado: (2020)

Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
por: Akhtar, Muhammad, et al.
Publicado: (2021)

Short-chain fatty acids in diseases
por: Zhang, Dan, et al.
Publicado: (2023)

Neuronal Activation in the Central Nervous System of Rats in the Initial Stage of Chronic Kidney Disease-Modulatory Effects of Losartan and Moxonidine
por: Palkovits, Miklós, et al.
Publicado: (2013)

The change of gut microbiota‐derived short‐chain fatty acids in diabetic kidney disease
por: Zhong, Chenyu, et al.
Publicado: (2021)

Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response
por: Adesso, Simona, et al.
Publicado: (2018)

The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids
por: Sam, Qi Hui, et al.
Publicado: (2021)

Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids
por: YAMAMURA, Ryodai, et al.
Publicado: (2019)

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s disease
por: Aho, Velma T. E., et al.
Publicado: (2021)

The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis
por: Visekruna, Alexander, et al.
Publicado: (2021)

Targeting endothelial dysfunction and oxidative stress in Long-COVID
por: Trimarco, Valentina, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Is Vitamin D Deficiency Related to Accumulation of Advanced Glycation End Products, Markers of Inflammation, and Oxidative Stress in Diabetic Subjects?
por: Šebeková, K., et al.
Publicado: (2015)

Short-chain fatty acids in cancer pathogenesis
por: Feitelson, Mark A., et al.
Publicado: (2023)

Fermentation of Foods and Beverages as a Tool for Increasing Availability of Bioactive Compounds. Focus on Short-Chain Fatty Acids
por: Annunziata, Giuseppe, et al.
Publicado: (2020)

Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?
por: Bellasi, Antonio, et al.
Publicado: (2014)

Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?
por: Becker, Anouck, et al.
Publicado: (2021)

Effect of Indoxyl Sulfate on the Repair and Intactness of Intestinal Epithelial Cells: Role of Reactive Oxygen Species’ Release
por: Adesso, Simona, et al.
Publicado: (2019)

Pro-Inflammatory Effects of Indoxyl Sulfate in Mice: Impairment of Intestinal Homeostasis and Immune Response
por: Rapa, Shara Francesca, et al.
Publicado: (2021)

Randomised clinical study: inulin short‐chain fatty acid esters for targeted delivery of short‐chain fatty acids to the human colon
por: Polyviou, T., et al.
Publicado: (2016)

The Combined Effects of Magnesium Oxide and Inulin on Intestinal Microbiota and Cecal Short-Chain Fatty Acids
por: Omori, Kanako, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mt6m74u1an14q3stb80usogi2b